2022 年の世界の抗てんかん薬 (AED) 市場は 93 億 9000 万ドルで、2028 年までに 114 億 7000 万ドルに達すると予想されます。抗てんかん薬 (AED) は、体内構造の包括的な画像を生成する非侵襲的画像技術の代表です。MRI は、強力な磁場と電波を使用することにより、高解像度の 3 次元画像を提供し、多くの場合、軟組織や臓器を非常に鮮明に描写します。MRI では、脳、脊髄、筋肉などの軟組織の詳細が向上し、電離放射線の使用が回避されるため、X 線や CT スキャンとは異なり、被ばくに伴うリスクが軽減されます。てんかんの世界的な発生率の増加により、強力な治療法の必要性が高まっています。世界保健機関によると、世界のてんかん患者数は 5,000 万人に近づき、この数は着実に増加すると考えられます。
近年、抗てんかん薬（AED）の必要性の高まりは、主に発作抑制における有効性の高まりにより注目に値します。これらの薬は副作用が少なくなったため、患者のコンプライアンスが向上しました。AED は、一般的なてんかん発作を治療するだけでなく、現在、さまざまなてんかん関連症候群の治療の中心となっています。その重要性は、個別化された神経学的治療のより広い領域に広がり、患者に合わせたケアを約束します。AED のこの進化は、患者に利益をもたらすだけでなく、医療業界の大幅な成長を促進し、現代の治療アプローチにおいて AED が不可欠なものとなっています。世界の抗てんかん薬（AED）市場は、2023年から2028年の予測期間中に3.39％のCAGRで成長すると予測されます。
目次
Table of Contents
1. Executive Summary
2. Introduction
2.1 Anti-Epileptic Drugs: An Overview
2.1.1 Definition of Anti-epileptic Drugs
2.1.2 Key Considerations of Anti-epileptic Drugs Selection
2.2 Anti-Epileptic Drugs Segmentation: An Overview
2.2.1 Anti-Epileptic Drugs Segmentation
3. Global Market Analysis
3.1 Global Anti-Epileptic Drugs Market: An Analysis
3.1.1 Global Anti-Epileptic Drugs Market: An Overview
3.1.2 Global Anti-Epileptic Drugs Market by Value
3.1.3 Global Anti-Epileptic Drugs Market by Drug Generation (First Generation, Second Generation, and Third Generation)
3.1.4 Global Anti-Epileptic Drugs Market by Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Online Providers)
3.1.5 Global Anti-Epileptic Drugs Market by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)
3.2 Global Anti-Epileptic Drugs Market: Drug Generation Analysis
3.2.1 Global Anti-Epileptic Drugs Market by Drug Generation: An Overview
3.2.2 Global First Generation Anti-Epileptic Drugs Market by Value
3.2.3 Global Second Generation Anti-Epileptic Drugs Market by Value
3.2.4 Global Third Generation Anti-Epileptic Drugs Market by Value
3.3 Global Anti-Epileptic Drugs Market: Distribution Channel Analysis
3.3.1 Global Anti-Epileptic Drugs Market by Distribution Channel: An Overview
3.3.2 Global Drug Stores & Retail Pharmacies Anti-Epileptic Drugs Market by Value
3.3.3 Global Hospital Pharmacies Anti-Epileptic Drugs Market by Value
3.3.4 Global Online Providers Anti-Epileptic Drugs Market by Value
4. Regional Market Analysis
4.1 North America Anti-Epileptic Drugs Market: An Analysis
4.1.1 North America Anti-Epileptic Drugs Market: An Overview
4.1.2 North America Anti-Epileptic Drugs Market by Value
4.1.3 North America Anti-Epileptic Drugs Market by Region (The US, Canada, and Mexico)
4.1.4 The US Anti-Epileptic Drugs Market by Value
4.1.5 Canada Anti-Epileptic Drugs Market by Value
4.1.6 Mexico Anti-Epileptic Drugs Market by Value
4.2 Europe Anti-Epileptic Drugs Market: An Analysis
4.2.1 Europe Anti-Epileptic Drugs Market: An Overview
4.2.2 Europe Anti-Epileptic Drugs Market by Value
4.2.3 Europe Anti-Epileptic Drugs Market by Region (Germany, the UK, France, Italy, Spain, and the Rest of Europe)
4.2.4 Germany Anti-Epileptic Drugs Market by Value
4.2.5 France Anti-Epileptic Drugs Market by Value
4.2.6 UK Anti-Epileptic Drugs Market by Value
4.2.7 Italy Anti-Epileptic Drugs Market by Value
4.2.8 Spain Anti-Epileptic Drugs Market by Value
4.2.9 Rest of Europe Anti-Epileptic Drugs Market by Value
4.3 Asia Pacific Anti-Epileptic Drugs Market: An Analysis
4.3.1 Asia Pacific Anti-Epileptic Drugs Market: An Overview
4.3.2 Asia Pacific Anti-Epileptic Drugs Market by Value
4.3.3 Asia Pacific Anti-Epileptic Drugs Market by Region (China, India, Japan, and Rest of Asia Pacific)
4.3.4 China Anti-Epileptic Drugs Market by Value
4.3.5 India Anti-Epileptic Drugs Market by Value
4.3.6 Japan Anti-Epileptic Drugs Market by Value
4.3.7 Rest of Asia Pacific Anti-Epileptic Drugs Market by Value
4.4 Latin America Anti-Epileptic Drugs Market: An Analysis
4.4.1 Latin America Anti-Epileptic Drugs Market: An Overview
4.4.2 Latin America Anti-Epileptic Drugs Market by Value
4.5 Middle East and Africa Anti-Epileptic Drugs Market: An Analysis
4.5.1 Middle East and Africa Anti-Epileptic Drugs Market: An Overview
4.5.2 Middle East and Africa Anti-Epileptic Drugs Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19 on Global Anti-Epileptic Drugs Market
5.2 Post-COVID-19 Impact on Global Anti-Epileptic Drugs Market
6. Market Dynamics
6.1 Growth Driver
6.1.1 Growth in Central Nervous System (CNS) Diseases
6.1.2 Growing Geriatric Population
6.1.3 Increasing Prevalence of Epilepsy
6.1.4 Government Initiatives and Funding
6.1.5 Enhanced Awareness and Advancements in Early Diagnosis Techniques
6.1.6 Global Expansion Of Pharmaceutical Companies
6.1.7 Involvement of Public-Private Partnerships
6.1.8 Advancement in Antiepileptic Drugs Development
6.2 Challenges
6.2.1 Patent Expirations
6.2.2 Lack of Accessibility and Associated Adverse Effects
6.3 Market Trends
6.3.1 Advancements in Artificial Intelligence (AI) and Machine Learning (ML)
6.3.2 Increasing Research & Development
6.3.3 Emerging Markets
6.3.4 Integration of Nasal Sprays as Rescue Therapy
6.3.5 Development of Drug Delivery Systems
6.3.6 Integration of Genomic Sequencing and Personalized Medicine
7. Competitive Landscape
7.1 Global Anti-Epileptic Drugs Market: Competitive Landscape
7.2 Global Anti-Epileptic Market Players: Brand Share
7.3 Global Anti-Epileptic Market Players: Generation Analysis
7.4 Global Anti-Epileptic Market Players: Drug Analysis
8. Company Profiles
8.1 Pfizer Inc.
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategies
8.2 UCB Inc.
8.2.1 Business Overview
8.2.2 Net Sales by Product
8.2.3 Business Strategies
8.3 Novartis AG
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategies
8.4 GlaxoSmithKline Plc
8.4.1 Business Overview
8.4.2 Sales by Products
8.4.3 Business Strategies
8.5 Sanofi S.A.
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy
8.6 Eisai Co. Ltd.
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategy
8.7 Johnson & Johnson (Janssen Pharmaceuticals)
8.7.1 Business Overview
8.7.2 Business Segments
8.7.3 Business Strategy
8.8 Takeda Pharmaceutical Company Limited
8.8.1 Business Overview
8.8.2 Revenue by Therapeutic Area
8.8.3 Business Strategy
8.9 Sumitomo Pharma Co., Ltd. (Sunovion Pharmaceuticals)
8.9.1 Business Overview
8.9.2 Reportable Segments
8.9.3 Business Strategy
8.10 Abbott Laboratories
8.10.1 Business Overview
8.10.2 Revenue by Category
8.10.3 Business Strategy
8.11 TEVA Pharmaceutical Industries Limited
8.11.1 Business Overview
8.11.2 Operating Segments
8.11.3 Business Strategy
8.12 Viatris Inc. (Mylan)
8.12.1 Business Overview
8.12.2 Operating Segments
8.12.3 Business Strategy
8.13 Merck & Co., Inc.
8.13.1 Business Overview
8.13.2 Operating Segments
8.13.3 Business Strategy
8.14 SK Biopharmaceuticals Co., Ltd.
8.14.1 Business Overview
8.14.2 Business Strategy
List of Figures
Figure 1: Key Considerations of Anti-epileptic Drugs Selection
Figure 2: Anti-Epileptic Drugs Segmentation
Figure 3: Global Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Billion)
Figure 4: Global Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Billion)
Figure 5: Global Anti-Epileptic Drugs Market by Drug Generation; 2022 (Percentage, %)
Figure 6: Global Anti-Epileptic Drugs Market by Distribution Channel; 2022 (Percentage, %)
Figure 7: Global Anti-Epileptic Drugs Market by Region; 2022 (Percentage, %)
Figure 8: Global First Generation Anti-Epileptic Drugs Market by Value, 2018-2022 (US$ Billion)
Figure 9: Global First Generation Anti-Epileptic Drugs Market by Value, 2023-2028 (US$ Billion)
Figure 10: Global Second Generation Anti-Epileptic Drugs Market by Value, 2018-2022 (US$ Billion)
Figure 11: Global Second Generation Anti-Epileptic Drugs Market by Value, 2023-2028 (US$ Billion)
Figure 12: Global Third Generation Anti-Epileptic Drugs Market by Value, 2018-2022 (US$ Million)
Figure 13: Global Third Generation Anti-Epileptic Drugs Market by Value, 2023-2028 (US$ Billion)
Figure 14: Global Drug Stores & Retail Pharmacies Anti-Epileptic Drugs Market by Value, 2018-2022 (US$ Billion)
Figure 15: Global Drug Stores & Retail Pharmacies Anti-Epileptic Drugs Market by Value, 2023-2028 (US$ Billion)
Figure 16: Global Hospital Pharmacies Anti-Epileptic Drugs Market by Value, 2018-2022 (US$ Billion)
Figure 17: Global Hospital Pharmacies Anti-Epileptic Drugs Market by Value, 2023-2028 (US$ Billion)
Figure 18: Global Online Providers Anti-Epileptic Drugs Market by Value, 2018-2022 (US$ Million)
Figure 19: Global Online Providers Anti-Epileptic Drugs Market by Value, 2023-2028 (US$ Million)
Figure 20: North America Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Billion)
Figure 21: North America Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Billion)
Figure 22: North America Anti-Epileptic Drugs Market by Region; 2022 (Percentage, %)
Figure 23: The US Anti-Epileptic Drugs Market by Value, 2018-2022 (US$ Billion)
Figure 24: The US Anti-Epileptic Drugs Market by Value, 2023-2028 (US$ Billion)
Figure 25: Canada Anti-Epileptic Drugs Market by Value, 2018-2022 (US$ Million)
Figure 26: Canada Anti-Epileptic Drugs Market by Value, 2023-2028 (US$ Million)
Figure 27: Mexico Anti-Epileptic Drugs Market by Value, 2018-2022 (US$ Million)
Figure 28: Mexico Anti-Epileptic Drugs Market by Value, 2023-2028 (US$ Million)
Figure 29: Europe Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Billion)
Figure 30: Europe Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Billion)
Figure 31: Europe Anti-Epileptic Drugs Market by Region; 2022 (Percentage, %)
Figure 32: Germany Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Million)
Figure 33: Germany Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Million)
Figure 34: France Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Million)
Figure 35: France Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Million)
Figure 36: UK Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Million)
Figure 37: UK Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Million)
Figure 38: Italy Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Million)
Figure 39: Italy Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Million)
Figure 40: Spain Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Million)
Figure 41: Spain Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Million)
Figure 42: Rest of Europe Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Million)
Figure 43: Rest of Europe Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Million)
Figure 44: Asia Pacific Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Billion)
Figure 45: Asia Pacific Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Billion)
Figure 46: Asia Pacific Anti-Epileptic Drugs Market by Region; 2022 (Percentage, %)
Figure 47: China Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Million)
Figure 48: China Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Million)
Figure 49: India Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Million)
Figure 50: India Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Million)
Figure 51: Japan Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Million)
Figure 52: Japan Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Million)
Figure 53: Rest of Asia Pacific Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Million)
Figure 54: Rest of Asia Pacific Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Million)
Figure 55: Latin America Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Million)
Figure 56: Latin America Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Million)
Figure 57: Middle East and Africa Anti-Epileptic Drugs Market by Value; 2018-2022 (US$ Million)
Figure 58: Middle East and Africa Anti-Epileptic Drugs Market by Value; 2023-2028 (US$ Million)
Figure 59: Global Central Nervous System (CNS) Disease Market; 2021-2026 (US$ Billion)
Figure 60: Global Population 65 Years and Above; 2017-2050 (Million)
Figure 61: Global Artificial Intelligence (AI) in Healthcare Market; 2021-2030 (US$ Billion)
Figure 62: Number of R&D Projects by Company
Figure 63: Global Anti-Epileptic Market Players by Brand Share; 2022 (Percentage, %)
Figure 64: Pfizer Inc. Revenue by Segment; 2022 (Percentage, %)
Figure 65: UCB Inc. Net Sales by Product; 2022 (Percentage, %)
Figure 66: Novartis AG Net Sales by Segment; 2022 (Percentage, %)
Figure 67: GlaxoSmithKline Plc Sales by Products; 2022 (Percentage, %)
Figure 68: Sanofi S.A. Net Sales by Segments; 2022 (Percentage, %)
Figure 69: Eisai Co. Ltd. Revenue by Segment; 2022 (Percentage, %)
Figure 70: Johnson & Johnson Sales by Business Segment; 2022 (Percentage, %)
Figure 71: Takeda Pharmaceutical Company Limited Revenue by Therapeutic Area; 2023 (Percentage, %)
Figure 72: Sumitomo Pharma Co., Ltd. Revenue by Reportable Segments; 2022 (Percentage, %)
Figure 73: Abbott Laboratories Revenue by Category; 2022 (Percentage, %)
Figure 74: TEVA Pharmaceutical Industries Ltd., Revenues by Segment; 2022 (Percentage, %)
Figure 75: Viatris Inc. Net Sales by Segment; 2022 (Percentage, %)
Figure 76: Merck & Co., Inc. Sales by Segments; 2022 (Percentage, %)
Table 1: Global Anti-Epileptic Market Players: Generation Analysis
Table 2: Global Anti-Epileptic Market Players: Drug Analysis
